The effectiveness of a new antiviral drug of plant origin in the form of eye drops in the complex therapy of ophthalmic herpes

Ophthalmic herpes is the most common infection-related cause of blindness in developing countries.Purpose: to evaluate the therapeutic efficacy, safety and tolerability of the drug Panavir® used as part of a combination therapy for herpetic superficial dendritic keratitis.Materials and methods. The...

Full description

Saved in:
Bibliographic Details
Main Authors: E. V. Yani, T. G. Kamenskikh, E. V. Veselova, T. G. Zubkova, S. V. Stovbun, K. E. Seliverstova, V. V. Pozdnyakova, M. M. Stupakova
Format: Article
Language:Russian
Published: Real Time Ltd 2023-10-01
Series:Российский офтальмологический журнал
Subjects:
Online Access:https://roj.igb.ru/jour/article/view/1307
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849243971844308992
author E. V. Yani
T. G. Kamenskikh
E. V. Veselova
T. G. Zubkova
S. V. Stovbun
K. E. Seliverstova
V. V. Pozdnyakova
M. M. Stupakova
author_facet E. V. Yani
T. G. Kamenskikh
E. V. Veselova
T. G. Zubkova
S. V. Stovbun
K. E. Seliverstova
V. V. Pozdnyakova
M. M. Stupakova
author_sort E. V. Yani
collection DOAJ
description Ophthalmic herpes is the most common infection-related cause of blindness in developing countries.Purpose: to evaluate the therapeutic efficacy, safety and tolerability of the drug Panavir® used as part of a combination therapy for herpetic superficial dendritic keratitis.Materials and methods. The study involved 106 patients aged 18 to 65 years divided into two groups. Group 1 (54 patients; 54 eyes) received treatment with Panavir® and Acyclovir ophthalmic ointment, whilst Group 2 (52 patients; 52 eyes) received a placebo of Panavir® and Acyclovir ophthalmic ointment. The primary parameter of the efficiency was the percentage of patients achieving clinical recovery, i.e. signs of complete epithelialization of the cornea.Results. In group 2 (monotherapy), a significantly greater number of patients with mild conjunctival hyperemia was registered than in the combination therapy group 1 — 59.26 vs. 23.08 %, p < 0.001. In group 1, the proportion of patients without corneal syndrome at visits 3 and 4 was, respectively, 11.11 and 61.11 %, while in group 2 it was only 3.85 and 19.61 %, respectively.Conclusion. The drug Panavir® eye drops 0.004 % showed a high therapeutic efficiency in the combined treatment of herpetic keratitis, and good tolerance. It also reduced the time required for corneal epithelialization and conjunctiva normalization.
format Article
id doaj-art-4dde387eab2f4c6f9fb262254565e93e
institution Kabale University
issn 2072-0076
2587-5760
language Russian
publishDate 2023-10-01
publisher Real Time Ltd
record_format Article
series Российский офтальмологический журнал
spelling doaj-art-4dde387eab2f4c6f9fb262254565e93e2025-08-20T03:59:17ZrusReal Time LtdРоссийский офтальмологический журнал2072-00762587-57602023-10-0116310411010.21516/2072-0076-2023-16-3-104-110618The effectiveness of a new antiviral drug of plant origin in the form of eye drops in the complex therapy of ophthalmic herpesE. V. Yani0T. G. Kamenskikh1E. V. Veselova2T. G. Zubkova3S. V. Stovbun4K. E. Seliverstova5V. V. Pozdnyakova6M. M. Stupakova7Helmholtz National Medical Research Center of Eye DiseasesSaratov V.I. Razumovsky State Medical UniversitySaratov V.I. Razumovsky State Medical UniversityA.A. Smorodintsev Research Institute of InfluenzaN.N. Semenov Research Center of Chemical Physics, Russian Academy of SciencesHelmholtz National Medical Research Center of Eye DiseasesHelmholtz National Medical Research Center of Eye DiseasesHelmholtz National Medical Research Center of Eye DiseasesOphthalmic herpes is the most common infection-related cause of blindness in developing countries.Purpose: to evaluate the therapeutic efficacy, safety and tolerability of the drug Panavir® used as part of a combination therapy for herpetic superficial dendritic keratitis.Materials and methods. The study involved 106 patients aged 18 to 65 years divided into two groups. Group 1 (54 patients; 54 eyes) received treatment with Panavir® and Acyclovir ophthalmic ointment, whilst Group 2 (52 patients; 52 eyes) received a placebo of Panavir® and Acyclovir ophthalmic ointment. The primary parameter of the efficiency was the percentage of patients achieving clinical recovery, i.e. signs of complete epithelialization of the cornea.Results. In group 2 (monotherapy), a significantly greater number of patients with mild conjunctival hyperemia was registered than in the combination therapy group 1 — 59.26 vs. 23.08 %, p < 0.001. In group 1, the proportion of patients without corneal syndrome at visits 3 and 4 was, respectively, 11.11 and 61.11 %, while in group 2 it was only 3.85 and 19.61 %, respectively.Conclusion. The drug Panavir® eye drops 0.004 % showed a high therapeutic efficiency in the combined treatment of herpetic keratitis, and good tolerance. It also reduced the time required for corneal epithelialization and conjunctiva normalization.https://roj.igb.ru/jour/article/view/1307herpeskeratitissolanum tuberosumpanavir®
spellingShingle E. V. Yani
T. G. Kamenskikh
E. V. Veselova
T. G. Zubkova
S. V. Stovbun
K. E. Seliverstova
V. V. Pozdnyakova
M. M. Stupakova
The effectiveness of a new antiviral drug of plant origin in the form of eye drops in the complex therapy of ophthalmic herpes
Российский офтальмологический журнал
herpes
keratitis
solanum tuberosum
panavir®
title The effectiveness of a new antiviral drug of plant origin in the form of eye drops in the complex therapy of ophthalmic herpes
title_full The effectiveness of a new antiviral drug of plant origin in the form of eye drops in the complex therapy of ophthalmic herpes
title_fullStr The effectiveness of a new antiviral drug of plant origin in the form of eye drops in the complex therapy of ophthalmic herpes
title_full_unstemmed The effectiveness of a new antiviral drug of plant origin in the form of eye drops in the complex therapy of ophthalmic herpes
title_short The effectiveness of a new antiviral drug of plant origin in the form of eye drops in the complex therapy of ophthalmic herpes
title_sort effectiveness of a new antiviral drug of plant origin in the form of eye drops in the complex therapy of ophthalmic herpes
topic herpes
keratitis
solanum tuberosum
panavir®
url https://roj.igb.ru/jour/article/view/1307
work_keys_str_mv AT evyani theeffectivenessofanewantiviraldrugofplantoriginintheformofeyedropsinthecomplextherapyofophthalmicherpes
AT tgkamenskikh theeffectivenessofanewantiviraldrugofplantoriginintheformofeyedropsinthecomplextherapyofophthalmicherpes
AT evveselova theeffectivenessofanewantiviraldrugofplantoriginintheformofeyedropsinthecomplextherapyofophthalmicherpes
AT tgzubkova theeffectivenessofanewantiviraldrugofplantoriginintheformofeyedropsinthecomplextherapyofophthalmicherpes
AT svstovbun theeffectivenessofanewantiviraldrugofplantoriginintheformofeyedropsinthecomplextherapyofophthalmicherpes
AT keseliverstova theeffectivenessofanewantiviraldrugofplantoriginintheformofeyedropsinthecomplextherapyofophthalmicherpes
AT vvpozdnyakova theeffectivenessofanewantiviraldrugofplantoriginintheformofeyedropsinthecomplextherapyofophthalmicherpes
AT mmstupakova theeffectivenessofanewantiviraldrugofplantoriginintheformofeyedropsinthecomplextherapyofophthalmicherpes
AT evyani effectivenessofanewantiviraldrugofplantoriginintheformofeyedropsinthecomplextherapyofophthalmicherpes
AT tgkamenskikh effectivenessofanewantiviraldrugofplantoriginintheformofeyedropsinthecomplextherapyofophthalmicherpes
AT evveselova effectivenessofanewantiviraldrugofplantoriginintheformofeyedropsinthecomplextherapyofophthalmicherpes
AT tgzubkova effectivenessofanewantiviraldrugofplantoriginintheformofeyedropsinthecomplextherapyofophthalmicherpes
AT svstovbun effectivenessofanewantiviraldrugofplantoriginintheformofeyedropsinthecomplextherapyofophthalmicherpes
AT keseliverstova effectivenessofanewantiviraldrugofplantoriginintheformofeyedropsinthecomplextherapyofophthalmicherpes
AT vvpozdnyakova effectivenessofanewantiviraldrugofplantoriginintheformofeyedropsinthecomplextherapyofophthalmicherpes
AT mmstupakova effectivenessofanewantiviraldrugofplantoriginintheformofeyedropsinthecomplextherapyofophthalmicherpes